Clinical Trial

Hemithoracic Arc Radiotherapy Post Pleural Decortication

Recruiting
View on ClinicalTrials.gov →
Summary
Malignant Pleural Mesothelioma is an aggressive and refractory disease , the most aggressive treatment plan offered to these patients include trimodalitiy approach with chemotherapy as the mainstay of treatment . the rationale of post operative Radiotherapy is to sterilize the post operative volume to reduce local failure meanwhile minimizing toxicities in this trial we are going to assess the safety and efficacy of Radiotherapy in Mesothelioma patients poat Pleural decortication
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-04-02.
Trial Details
NCT Number NCT06910449
Lead Sponsor Cairo University
Conditions Malignant Pleural Mesothelioma
Enrollment 45 participants
Start Date 2024-11-11
Primary Completion 2026-11 (estimated)
Study Completion 2027-02 (estimated)
Updated on ClinicalTrials.gov 2025-04-08